These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23416667)

  • 61. Federal grants to small employers for comprehensive wellness programs: passed as part of health care reform.
    O'Donnell MP
    Am J Health Promot; 2010; 25(1):iv-v. PubMed ID: 20809823
    [No Abstract]   [Full Text] [Related]  

  • 62. Common Fund programs: what are they and are you eligible for funding?
    Wilder EL
    Physiologist; 2012 Oct; 55(5):179-80. PubMed ID: 23155927
    [No Abstract]   [Full Text] [Related]  

  • 63. Confidentiality of research grant protocols.
    Morgan TE; Keyes JA; Sherman JF
    Clin Res; 1976 Jan; 24(1):5-12. PubMed ID: 10277868
    [No Abstract]   [Full Text] [Related]  

  • 64. Editorial: And yet another crisis: research funding in anesthesiology.
    Kitz RJ; Biebuyck JF
    Anesthesiology; 1974 Mar; 40(3):211-4. PubMed ID: 4814242
    [No Abstract]   [Full Text] [Related]  

  • 65. Federal grant support of optometric research and education.
    Watzman N
    Am J Optom Arch Am Acad Optom; 1971 Apr; 48(4):357-64. PubMed ID: 5279856
    [No Abstract]   [Full Text] [Related]  

  • 66. Editorial: Digestive diseases as a national problem: public policy and funding for biomedical research.
    Strickland SP
    Gastroenterology; 1974 Aug; 67(2):379-81. PubMed ID: 4847716
    [No Abstract]   [Full Text] [Related]  

  • 67. National Institutes of Health. Two strikes and you're out, grant applicants learn.
    Kaiser J
    Science; 2008 Oct; 322(5900):358. PubMed ID: 18927363
    [No Abstract]   [Full Text] [Related]  

  • 68. Taking the profit out of biomedical research tools.
    Flores MA
    Nat Biotechnol; 1999 Aug; 17(8):819-20. PubMed ID: 10429252
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Perspective: is NIH funding the "best science by the best scientists"? A critique of the NIH R01 research grant review policies.
    Costello LC
    Acad Med; 2010 May; 85(5):775-9. PubMed ID: 20520024
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New and evolving rare diseases research programs at the National Institutes of Health.
    Groft SC; Rubinstein YR
    Public Health Genomics; 2013; 16(6):259-67. PubMed ID: 24503586
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An analysis of the NIH-supported sickle cell disease research portfolio.
    Gavini N; Hoots WK; Mensah GA; Hanspal M
    Blood Cells Mol Dis; 2015 Feb; 54(2):198-205. PubMed ID: 25466208
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The NHLBI-UnitedHealth Global Health Centers of Excellence Program: Assessment of Impact of Federal Funding Through a Social Network Analysis.
    Dianis NL; Wolbach TL; Spiegelman M
    Glob Heart; 2016 Mar; 11(1):145-148.e1. PubMed ID: 27102034
    [No Abstract]   [Full Text] [Related]  

  • 73. Fostering Diversity and Inclusion in the National Heart, Lung, and Blood Institute's Small Business Program.
    Padmore EW; McMahon MJ
    Ethn Dis; 2019; 29(Suppl 1):71-76. PubMed ID: 30906152
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Training, career development, and small business support from the National Institutes of Health.
    Podskalny J
    Gastrointest Endosc; 1999 Mar; 49(3 Pt 2):S96-9. PubMed ID: 10049460
    [No Abstract]   [Full Text] [Related]  

  • 75. Hydrocephalus research funding from the National Institutes of Health: a 10-year perspective.
    Gross P; Reed GT; Engelmann R; Kestle JR
    J Neurosurg Pediatr; 2014 Feb; 13(2):145-50. PubMed ID: 24313657
    [TBL] [Abstract][Full Text] [Related]  

  • 76. What strategy should France implement for H2020?
    Dhainaut JF; Diebolt V; Pouletty-Lefèbvre B; ; Baker A; Bassompierre F; Borel T; Braunstein D; Demotes J; François B; Huet S; Micallef J; Misse C; Molon A; Rascol O; Ravoire S; Schwartz B; Donne N; Donne N; Fusaï G; Pouletty P; Vicaut E
    Therapie; 2015; 70(1):95-109. PubMed ID: 25747841
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Funding. NIH program fails to launch blacks in biotech.
    Mervis J
    Science; 2015 Nov; 350(6263):896. PubMed ID: 26586739
    [No Abstract]   [Full Text] [Related]  

  • 78. Seeking innovation: incentive funding for biodefense biotechs.
    Nolan JM; Samad EU; Jindra LF; Brozak SG
    Biosecur Bioterror; 2010 Dec; 8(4):365-72. PubMed ID: 21142763
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Advancing pediatric medical device development via non-dilutive NIH SBIR/STTR grant funding.
    Sun RC; Kamat I; Byju AG; Wettergreen M; Heffernan MJ; Willson R; Haridas B; Koh CJ
    J Pediatr Surg; 2021 Nov; 56(11):2118-2123. PubMed ID: 33558071
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.